February 13, 2026 · Form 4 insider transaction
Bhatia Sangeeta N. sold 266 shares of Vertex Pharmaceuticals Incorporated at $500.00 per share, a transaction worth $133.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025.